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Growing evidence shows that cellular metabolism is a key determinant of stem
cell fate. In recognition of this growing area of research, Cell Stem Cell and Cell
Metabolism have teamed up with academic co-organizers Drs. Emmanuelle
Passegue´ and Michael Teitell for our upcoming Cell Symposium, Stem Cell
Energetics, which takes place December 9th –11th, 2014. In anticipation of the
meeting, we asked speakers to discuss what drives them to study this topic,
including key findings and burning questions. In a Voices piece that appears
in this issue (and the December 2, 2014 issue of Cell Metabolism), a selection
of speakers share their thoughts.
The Journey from the Crypt to the Clinic
ZEUNER ET AL., 692
This Review presents a current understanding of colorectal CSCs, including
their origin, relationship to stem cells of the intestine, phenotypic characteriza-tion, and underlying regulatory mechanisms. Limitations to current preclinical models of colorectal cancer and how under-
standing CSC plasticity can improve the development of clinical strategies are also covered.
M6Arking ESCs for Differentiation
BATISTA ET AL., 707
N6-methyl-adenosine (m6A) is themost abundantmodification onmessenger RNAs. Batista et al. show that core pluripotency
factors are regulated by m6A, and depletion of m6A levels by inactivation of Mettl3 impairs ESC exit from self-renewal and
blocks differentiation. Preview by Jalkanen and Wilusz.
Nucleolar Regulation of Pluripotency
SAVIC ET AL., 720 AND LEE ET AL., 735
Savic et al. show that heterochromatin condensation in the nucleolus, where ribosomal genes are transcribed, triggers re-
modeling of open ESC chromatin into a highly condensed heterochromatic structure and stimulates exit from pluripotency
via activation of differentiation genes. Kim et al. reveal that LIN28A, which is methylated by SET7/9, multimerizes to sequester
and prevent biogenesis of pri-let-7 in the nucleoli of hESCs, thereby modulating their pluripotency. Preview by Feinberg.
Using Estrogens to Target Leukemia
SA´NCHEZ-AGUILERA ET AL., 791
Activation of estrogen receptor (ER) signaling induces apoptosis in MPPs, but induces proliferation of HSCs, in a reversible
manner. ER activation with tamoxifen blocks development of myeloproliferative neoplasm by restoring normal apoptosis
levels in mutant cells and induces apoptosis of AML blasts, in combination with conventional chemotherapy. (Top image.)
Patching up Broken Hearts
YE ET AL., 750
Engraftment of hPSC-derived cardiomyocytes, endothelial cells, and smooth
muscle cells into a large animal model of myocardial infarction improves heart
function and metabolism without inducing ventricular arrhythmias. Preview by
Serpooshan and Wu.
Defeating LSCs by Depleting Telomerase
BRUEDIGAM ET AL., 775
Bruedigam et al. show that inhibiting telomerase in bothmouse and human AML
targets and depletes LSCs, impairs leukemic progression, and delays relapse
after chemotherapy. Preview by Kuo and Bhatia. (Bottom image.)
Stromal MicroRNAs Promote Breast Cancer
Metastasis
CUIFFO ET AL., 762
Repression of FOXP2 by a network of mesenchymal-stem-cell-regulated
microRNAs facilitates the acquisition of cancer stem cell andmetastatic pheno-
types by breast cancer cells.Cell Stem Cell 15, December 4, 2014 ª2014 Elsevier Inc. xiii
